Generation of human induced pluripotent stem cells (hIPSCs) from sialidosis types I and II patients with pathogenic neuraminidase 1 mutations
Sialidosis is an autosomal recessive lysosomal storage disease, belonging to the glycoproteinoses. The disease is caused by deficiency of the sialic acid-cleaving enzyme, sialidase 1 or neuraminidase 1 (NEU1). Patients with sialidosis are classified based on the age of onset and severity of the clin...
Main Authors: | Min-Joon Han, Ida Annunziata, Jason Weesner, Yvan Campos, Muneeb Salie, Carla O'Reilly, Alessandra d'Azzo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506120301379 |
Similar Items
-
Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I
by: Rosario Mosca, et al.
Published: (2020-03-01) -
Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation
by: Shih-Ping Liu, et al.
Published: (2018-04-01) -
Modeling Sialidosis with Neural Precursor Cells Derived from Patient-Derived Induced Pluripotent Stem Cells
by: Binna Seol, et al.
Published: (2021-04-01) -
Sialylation of host proteins as targetable risk factor for COVID‐19 susceptibility and spreading: A hypothesis
by: Antonella Bongiovanni, et al.
Published: (2021-03-01) -
An iPSC-based neural model of sialidosis uncovers glycolytic impairment-causing presynaptic dysfunction and deregulation of Ca2+ dynamics
by: Haruki Odaka, et al.
Published: (2021-05-01)